Humacyte, Inc. (HUMA) — Financial statements
Income statement, balance sheet, and cash flow for Humacyte, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 2 | 0.00 | 0.00↓100.0% | 2↑23.9% | 1 | |
| Cost of Revenue | 17↑137.1% | 7↓90.6% | 77↑827.3% | 8↓86.5% | 61 | |
| Gross Profit | -15↓108.7% | -7↑90.6% | -77↓1044.2% | -7↑88.9% | -60 | |
| Operating Expenses | ||||||
| R&D Expenses | 69↓21.8% | 89↑15.7% | 77↑21.0% | 63↑3.1% | 61 | |
| General & Administrative Expenses | 31↑20.8% | 26↑10.3% | 23↑2.2% | 23↑8.8% | 21 | |
| Selling & Marketing Expenses | 0.00 | 0.00↑100.0% | -3 | 0.00↓100.0% | 0.11 | |
| SG&A Expenses | 31↑20.8% | 26↑26.5% | 20↓10.9% | 23↑8.3% | 21 | |
| Other Expenses | -8↓11.9% | -7↑90.2% | -73↓789.7% | -8↑86.5% | -61 | |
| Operating Expenses | 92↓13.8% | 107↑356.3% | 23↓69.8% | 78↑268.6% | 21 | |
| Total Costs & Expenses | 109↓4.3% | 114↑14.3% | 100↑16.1% | 86↑4.5% | 82 | |
| Operating Results | ||||||
| Operating Income | -107↑6.1% | -114↓14.3% | -100↓18.3% | -85↓4.1% | -81 | |
| Depreciation & Amortization | 7↑2.2% | 7↓6.9% | 8↓6.0% | 8↓0.4% | 8 | |
| EBITDA | -100↑24.3% | -132↓37.1% | -96↓26.3% | -76↓4.7% | -73 | |
| EBIT | -107↑22.9% | -139↓33.8% | -104↓23.2% | -85↓4.1% | -81 | |
| Interest & Other Income | ||||||
| Net Interest Income | -9↓67.5% | -5↓357.0% | -1↑68.3% | -4↑17.6% | -4 | |
| Interest Income | 3↓37.0% | 4↓24.9% | 5↑107.9% | 3↑16331.3% | 0.02 | |
| Interest Expense | 11↑21.3% | 9↑40.6% | 7↑6.4% | 6↑42.6% | 4 | |
| Non-Operating Income | 0.00↓100.0% | 25↑506.0% | 4 | 0.00 | 0.00 | |
| Other Income / Expenses | 67↑294.2% | -34↓219.7% | -11↓114.8% | 73↑32.7% | 55 | |
| Income Before Tax | -41↑72.5% | -149↓34.2% | -111↓825.8% | -12↑54.8% | -26 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -41↑72.5% | -149↓34.2% | -111↓825.8% | -12↑54.8% | -26 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -41↑72.5% | -149↓34.2% | -111↓825.8% | -12↑54.8% | -26 | |
| Bottom-Line Net Income | -41↑72.5% | -149↓34.2% | -111↓825.8% | -12↑54.8% | -26 | |
| EPS (Basic) | -0.26↑79.4% | -1.26↓17.8% | -1.07↓791.7% | -0.12↑81.8% | -0.66 | |
| EPS (Diluted) | -0.26↑79.4% | -1.26↓17.8% | -1.07↓791.7% | -0.12↑81.8% | -0.66 | |
| Weighted Average Shares | 158↑33.5% | 118↑14.6% | 103↑0.4% | 103↑157.8% | 40 | |
| Weighted Average Diluted Shares | 158↑33.5% | 118↑14.6% | 103↑0.4% | 103↑157.8% | 40 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.